INVESTOR PRESENTATION October 2025 DISCLAIMER Forward-Looking Statements: This presentation by Ryan Specialty Holdings, Inc. (the "Company," "we," "us") contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve substantial risks and uncertainties and that reflect the Company's current expectations and projections with respect to, among other things, its plans, objectives, and business. These forward- looking statements may include words suc ...

Simplified Portfolio with Successful Closing on Sale of Self Service Segment Returned $118 Million of Capital to Shareholders; $40 Million of Share Repurchases and $78 Million in Cash Dividends Raised Midpoint and Narrowed Range for Full Year 2025 EPS Outlook Following Sale of Self Service ANTIOCH, Tenn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) today reported third quarter 2025 financial results and updates outlook for 2025 following the sale of the Company's Self Service segment. Fo ...

2025 Third quarter trading statement October 2025 Disclaimer This presentation contains certain statements that are, or may be deemed to be, "forward-looking statements" (including for purposes of the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). Forward-looking statements give Haleon's current expectations and projections about future events, including strategic initiatives and future fin ...

Key Points Fiserv's third-quarter report arrived with huge sales and earnings misses. The company also issued major downward revisions for its organic revenue growth and earnings targets. Organic revenue growth is now expected to come in at roughly 4%, and adjusted earnings per share are projected to dip slightly. 10 stocks we like better than Fiserv › Fiserv (NYSE: FI) stock is getting crushed in Wednesday's trading following a very disappointing quarterly report. The fintech company's share pric ...

Rentokil Initial (NYSE:RTO) Q3 2025 Earnings Call October 23, 2025 04:00 AM ET Company ParticipantsPaul Johnson - CFOSuhasini Varanasi - VPNone - Unknown Speaker 1Annelies Vermeulen - Head of Business Services Equity ResearchAndy Ransom - CEOConference Call ParticipantsAllen Wells - Equity Research AnalystWilliam Kirkness - Equity Research AnalystOllie Davies - Equity AnalystJames Rosenthal - VP and Equity Research AnalystNicole Manion - Equity AnalystOperatorGood morning, everyone, and welcome to the Rento ...

While reporting financial results for the third quarter on Tuesday, beverages giant Coca-Cola Co. (KO) maintained its adjusted earnings and organic revenue growth guidance for the full-year 2025. The company also provided outlook for the fourth quarter.For fiscal 2025, the company continues to project comparable currency neutral earnings growth of approximately 8 percent, and comparable earnings per share growth of approximately 3 percent from the $2.88 per share reported in 2024, implying earnings of $2.9 ...

Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty ImagesSOPA Images/LightRocket via Getty ImagesCoca-Cola HBC’s share price dropped on Tuesday after the company announced significant acquisition activity in Africa and published third-quarter trading numbers.Shares in the FTSE 100 soft drinks bottler were last 4% lower on Tuesday, at £33.98 per share.Coca-Cola HBC said it had agreed to buy a 75% stake in in Coca-Cola Beverages Africa for $2.6 billion. It has also entered an option agreem ...

核心财务业绩 - 第二季度营收为8.971亿美元，同比增长5%，去年同期为8.558亿美元 [1] - 第二季度净利润为3500万美元，摊薄后每股收益为0.29美元，去年同期净利润为6310万美元，摊薄后每股收益为0.53美元 [1] - 第二季度调整后每股收益为0.45美元，高于去年同期的0.39美元 [1] - 第二季度运营收入为5310万美元，较去年同期的9000万美元下降3690万美元 [7] - 第二季度调整后运营收入为7530万美元，较去年同期的6850万美元增长680万美元 [7] - 第二季度毛利率为34.4%，较去年同期下降10个基点 [8] - 过去四个季度调整后EBITDA为2.783亿美元，占营收的8.5% [11] 并购交易 - 公司于2025年8月3日与HNI Corporation达成合并协议，HNI将以现金和股票交易方式收购公司，总对价约22亿美元 [2] - 交易预计在2025日历年年底前完成，需获得HNI和公司股东批准、相关监管批准以及其他惯例成交条件满足 [2] 分区域业绩 - 美洲地区营收为7.071亿美元，同比增长3%，有机增长3% [3][13] - 国际地区营收为1.9亿美元，同比增长13%，有机增长8% [3][13] - 美洲地区运营收入为6770万美元，去年同期为1.02亿美元 [5][14] - 国际地区运营亏损为1460万美元，去年同期运营亏损为1200万美元 [5][14] - 美洲地区订单增长8%，国际地区订单下降1% [4] 运营指标驱动因素 - 营收增长主要由美洲地区大型企业客户需求增强以及印度市场驱动 [3][6] - 美洲地区增长来自大型企业客户，部分被教育客户需求下降所抵消 [3] - 国际地区增长由印度、中国和英国驱动，部分被法国和德国下降所抵消 [3] - 订单增长主要由美洲地区大型企业客户持续增长驱动 [4][6] 成本与费用 - 运营费用为2.471亿美元，较去年同期增加4200万美元 [9] - 费用增加主要由于土地出售收益减少3960万美元、合并交易成本710万美元、不利汇率影响310万美元以及非员工董事递延补偿费用增加260万美元 [9] - 部分被可变补偿费用减少830万美元所抵消 [9] 现金流与资产负债表 - 总流动性（包括现金及现金等价物、短期投资和公司拥有的人寿保险现金退保价值）为4.268亿美元，较去年同期减少8030万美元 [11] - 总债务为4.474亿美元 [11] - 董事会宣布季度现金股息为每股0.10美元，将于2025年10月20日或之前支付给2025年10月6日登记在册的股东 [12]

We begin this hour with a leadership shakeup at Bank of America. Brian Moynihan recently naming Dave Athanasiou and Jim Demark as co-presidents. The firm writing in a statement, quote, Athanasiou and Demarr will drive company wide initiatives focused on long term growth and returns and oversee Bank of America's eight lines of business.I'm very pleased to say that. Joining us now is the Bank of America chat CEO Brian Moynihan. Brian, of course, in London, we're here in New York.You're actually in our home an ...

财务表现 - 公司第一季度调整后每股收益(EPS)为1.26美元 同比增长2.4% 超出市场预期2.4% [1] - 按GAAP计算的每股收益为81美分 同比增长1.3% [1] - 全球营收达85.8亿美元 同比增长8.3%(按报告基准) 有机增长4.8% 超出预期2.5% [3] - 调整后运营利润率同比扩大81个基点至23.8% [8] 股价与公司治理 - 公告后股价在盘前交易中下跌3.1% [2] - 新增两名独立董事并成立两个专注于增长和运营的特别董事会委员会 [2] 业务部门表现 心血管业务 - 营收32.3亿美元 有机增长7% [5] - 心脏节律与心衰业务17.1亿美元 有机增长9.1% [5] - 结构性心脏与主动脉业务9.3亿美元 有机增长6.1% [5] - 冠状动脉与外周血管业务6.43亿美元 有机增长2.9% [5] 医疗外科业务 - 总营收20.8亿美元 有机增长2.4% [6] - 外科与内窥镜业务16.1亿美元 有机增长2.3% [6] - 急症护理与监测业务4.71亿美元 有机增长2.6% [6] 神经科学业务 - 总营收24.2亿美元 有机增长3.1% [7] - 颅脑与脊柱技术业务12.1亿美元 有机增长4.5% [7] - 专科治疗业务7.02亿美元 有机下降2.7% [7] - 神经调控业务5.04亿美元 有机增长8.6% [7] 糖尿病业务 - 营收7.21亿美元 有机增长7.9% [7] 成本与支出 - 毛利率下降10个基点至65% 主要因营收成本上升8.7% [8] - 研发支出7.26亿美元 同比增长7.4% [8] - 销售及行政支出28.1亿美元 同比增长5.7% [8] 业绩展望 - 上调2026财年EPS预期至5.60-5.66美元 [10] - 维持全年有机营收增长5%的预期 [11] - 考虑汇率影响后 预计报告基准营收增长6.5-6.8% [11] - 市场共识预期2026财年营收352.9亿美元 同比增长5.2% [12] 业务亮点 - 心脏消融解决方案营收增长近50% 其中美国市场增长72% [13] - 获得Hugo机器人辅助手术系统LigaSure RAS血管密封技术的CE认证 [13]